BioCentury | Jan 7, 2021
Deals

Jan. 6 Quick Takes:  Ribometrix gets $25M up front in Genentech RNA deal; plus Dewpoint-Pfizer, Kite-Oxford BioTherapeutics, Illumina-Helix and more

...discovery, clinical and regulatory milestones, plus royalties.Illumina, Helix...
...for new SARS-CoV-2 variantsIllumina Inc. (NASDAQ:ILMN) and Helix...
BioCentury | Oct 8, 2020
Finance

Data Bytes: RADx funding recipients

...Golovin NIH Luminostics Inc. Quanterix Corp. Quidel Corp. Sonic Healthcare Illumina Inc. Ceres Nanosciences Inc. Broad Institute Aegis Sciences Mesa Biotech Inc. Talis Biomedical Corp. Mammoth Biosciences Fluidigm Corp. Helix...
BioCentury | Sep 29, 2020
Product Development

Alzheimer milestones & vaccine politics: a BioCentury podcast

...Before we go, I just wanted to let you know about our 7th Annual BioCentury-Bay Helix...
BioCentury | Jun 11, 2020
Deals

Prism’s peptide mimetic platform finds second discovery partner

...Ingelheim GmbH, which has options to license and develop any resulting compounds. Prism’s library comprises α-helix...
...estimate which part of the target protein’s amino acid sequence is likely to form a helix...
BioCentury | Sep 10, 2019
Emerging Company Profile

Trucode: advancing nuclease-free, viral vector-independent gene therapy

...nucleic acid (PNA) technology from Peter Glazer’s lab at Yale University. In 2006, Glazer co-founded Helix...
...a non-exclusive license to the gene editing technology, but the company is no longer active. “Helix...
...and zinc finger nucleases (ZFNs). Instead of cutting the DNA, PNAs open up DNA’s double-stranded helix...
BioCentury | Aug 29, 2019
Distillery Techniques

Counting uninterrupted CAG triplets in HTT gene to predict age of onset for Huntington disease

...Aug. 8, 2019 doi: 10.1016/j.cell.2019.06.036 CONTACT: James F. Gusella, Harvard Medical School, Boston, Mass. e-mail: gusella@helix.mgh.harvard.edu...
BioCentury | Aug 1, 2019
Product Development

NeuBase takes antisense oligos to more targets in more places

...start, a right-handed helical structure complimentary to that of an RNA hairpin or a DNA double-helix...
BioCentury | Nov 28, 2018
Emerging Company Profile

Cybrexa: pH-based tumor targeting

...cancer agent to a pH-sensitive peptide via an undisclosed linker. The peptide forms a transmembrane α-helix...
BioCentury | Nov 16, 2018
Clinical News

BioCardia's CardiAMP non-significantly improves 6MWD in roll-in cohort of Phase III for heart failure

...CardiAMP, which comprises autologous bone marrow-derived cells delivered into the heart muscle using the company's Helix...
...Molecular target: NA Description: Autologous bone marrow-derived cells delivered into the heart muscle using the Helix...
BioCentury | Nov 2, 2018
Targets & Mechanisms

FDA’s pediatric target picks

...include transcriptional repressors containing ankyrin repeat domains or zinc finger domains; transcriptional activators containing basic helix-loop-helix...
Items per page:
1 - 10 of 372
BioCentury | Jan 7, 2021
Deals

Jan. 6 Quick Takes:  Ribometrix gets $25M up front in Genentech RNA deal; plus Dewpoint-Pfizer, Kite-Oxford BioTherapeutics, Illumina-Helix and more

...discovery, clinical and regulatory milestones, plus royalties.Illumina, Helix...
...for new SARS-CoV-2 variantsIllumina Inc. (NASDAQ:ILMN) and Helix...
BioCentury | Oct 8, 2020
Finance

Data Bytes: RADx funding recipients

...Golovin NIH Luminostics Inc. Quanterix Corp. Quidel Corp. Sonic Healthcare Illumina Inc. Ceres Nanosciences Inc. Broad Institute Aegis Sciences Mesa Biotech Inc. Talis Biomedical Corp. Mammoth Biosciences Fluidigm Corp. Helix...
BioCentury | Sep 29, 2020
Product Development

Alzheimer milestones & vaccine politics: a BioCentury podcast

...Before we go, I just wanted to let you know about our 7th Annual BioCentury-Bay Helix...
BioCentury | Jun 11, 2020
Deals

Prism’s peptide mimetic platform finds second discovery partner

...Ingelheim GmbH, which has options to license and develop any resulting compounds. Prism’s library comprises α-helix...
...estimate which part of the target protein’s amino acid sequence is likely to form a helix...
BioCentury | Sep 10, 2019
Emerging Company Profile

Trucode: advancing nuclease-free, viral vector-independent gene therapy

...nucleic acid (PNA) technology from Peter Glazer’s lab at Yale University. In 2006, Glazer co-founded Helix...
...a non-exclusive license to the gene editing technology, but the company is no longer active. “Helix...
...and zinc finger nucleases (ZFNs). Instead of cutting the DNA, PNAs open up DNA’s double-stranded helix...
BioCentury | Aug 29, 2019
Distillery Techniques

Counting uninterrupted CAG triplets in HTT gene to predict age of onset for Huntington disease

...Aug. 8, 2019 doi: 10.1016/j.cell.2019.06.036 CONTACT: James F. Gusella, Harvard Medical School, Boston, Mass. e-mail: gusella@helix.mgh.harvard.edu...
BioCentury | Aug 1, 2019
Product Development

NeuBase takes antisense oligos to more targets in more places

...start, a right-handed helical structure complimentary to that of an RNA hairpin or a DNA double-helix...
BioCentury | Nov 28, 2018
Emerging Company Profile

Cybrexa: pH-based tumor targeting

...cancer agent to a pH-sensitive peptide via an undisclosed linker. The peptide forms a transmembrane α-helix...
BioCentury | Nov 16, 2018
Clinical News

BioCardia's CardiAMP non-significantly improves 6MWD in roll-in cohort of Phase III for heart failure

...CardiAMP, which comprises autologous bone marrow-derived cells delivered into the heart muscle using the company's Helix...
...Molecular target: NA Description: Autologous bone marrow-derived cells delivered into the heart muscle using the Helix...
BioCentury | Nov 2, 2018
Targets & Mechanisms

FDA’s pediatric target picks

...include transcriptional repressors containing ankyrin repeat domains or zinc finger domains; transcriptional activators containing basic helix-loop-helix...
Items per page:
1 - 10 of 372